Table 1. Bilateral risk reducing NSM using hydrodissection in women with no co-morbidity.

Patient	Age (years)	Hammock type	Hammock size	Implant type	Implant size (cc)	Drain days	Complications minor/major	Outcome achieved	Follow up months
1	28	None	-	Silicone	300	14	Mi	Y	32
2	39	ADM	8×16	Silicone	300	13	None	Y	31
3	30	ADM	8×16	Silicone	550	12	None	Y	30
4	49	ADM	8×16	Becker50/50	400	14	None	Y	21
5	49	ADM	8×16	Silicone	225	15	None	Y	20
6	46*	ADM	8×20	Silicone	475	14	None	Y	16
7	45	ADM	8×20	Expander	550	21	None	Y	15
8	41	ADM	8×16	Silicone	440	21	None	Y	12
9	53	ADM	8×20	Silicone	555	12	None	Y	11
10	49	ADM	8×20	Silicone	475	11	Mi	Y	10
11	40	ADM	8×16	Silicone	475	14	None	Y	9
12	38	ADM	8×16	Silicone	325	12	None	Y	8
13	45*	ADM	8×16	Silicone	420	15	None	Y	8
14	34	ADM	8×16	Silicone	440	11	None	Y	7
15	32	ADM	8×16	Silicone	420	7	None	Y	6
16	38*	ADM	8×20	Silicone	590	12	None	Y	5
17	43	ADM	8×20	Silicone	515	9	None	Y	3
18	42	ADM	8×16	Silicone	440	14	None	Y	3
19	47*	ADM	8×16	Silicone	440	14	None	Y	2
20	50	ADM	8×20	Silicone	700	11	None	Y	1

*, pre-reduction 3 months prior to NSM. NSM, nipple sparing mastectomy; ADM, acellular dermal matrix.